Chief Executive Officer (CEO) is Mr. Hans Balz, Germany. Mr. Balz is MBA and has many years in experience in the pharma business as certified clinical consultant and as Director of a global acting pharma company.

Chief Research Director (CRD) is Dr. Richard Honour, USA. Richard Honour is PhD and responsible for research and product development. Dr. Honour has many years of experience as CEO in medical research companies.

Chief Development Director (CDD) is Dr. Warren Wheeler, USA. Mr. Wheeler is MBA and owns long-term experience in development of valuable medical companies in positions at the board of directors as well as in other responsible positions.

Vice President Investor Relations (VPIR) is Mr. Nicos Afedulidis, Greece. Mr. Afedulidis has many years of experience in the finance sector and is specialized in investment management.